Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
bimatoprost 0.03%/timolol 0.5% combination ophthalmic solution
latanoprost 0.005% ophthalmic solution
Locations
2
Portugal
Coimbra, Portugal
Madrid, Spain
Start Date
June 1, 2010
Primary Completion Date
February 14, 2012
Completion Date
February 14, 2012
Last Updated
April 18, 2019
NCT05885022
NCT06201455
NCT05624398
NCT05325996
NCT05044793
NCT03868124
Lead Sponsor
Allergan
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions